Fennec Pharmaceuticals (FENC) Research & Development (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Research & Development of $18.4 million for Q4 2025, up 252.9% on a QoQ basis from $5.2 million in Q3 2025, and up 366.18% year-over-year from $3.9 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Research & Development (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Research & Development history runs 16 years deep, the most recent figure standing at $18.4 million for Q4 2025.
- Quarterly Research & Development rose 366.18% year-over-year to $18.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.6 million (up 101.59% YoY) and the FY2025 annual result came in at $18.6 million, up 1.03% from the prior year.
- Research & Development was $18.4 million for Q4 2025 at Fennec Pharmaceuticals, up from $5.2 million in the prior quarter.
- Across five years, Research & Development topped out at $18.4 million in Q4 2025 and bottomed at $3000.0 in Q1 2024.
- A 5-year average of $2.6 million and a median of $1.2 million in 2021 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development slumped 99.72% — and 2025, when it soared 98133.33%.
- Fennec Pharmaceuticals' Research & Development stood at $523000.0 in 2021, then slumped by 77.63% to $117000.0 in 2022, then plunged by 72.65% to $32000.0 in 2023, then soared by 12225.0% to $3.9 million in 2024, then soared by 366.18% to $18.4 million in 2025.
- Business Quant data shows FENC's Research & Development at $18.4 million in Q4 2025, $5.2 million in Q3 2025, and $107000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | 18.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.39 Mn |
| Sep 30, 2025 | 5.21 Mn |
| Jun 30, 2025 | 107,000.00 |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Sep 30, 2024 | 4.60 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 117,000.00 |
| Sep 30, 2022 | 846,000.00 |
| Jun 30, 2022 | 1.13 Mn |
| Mar 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | 523,000.00 |
| Sep 30, 2021 | 1.24 Mn |
| Jun 30, 2021 | 800,000.00 |
| Mar 31, 2021 | 2.42 Mn |